These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18037319)

  • 1. Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with rheumatoid arthritis.
    Fautrel B; Pham T; Mouterde G; Le Loët X; Goupille P; Guillemin F; Ravaud P; Cantagrel A; Dougados M; Puéchal X; Sibilia J; Soubrier M; Mariette X; Combe B; ;
    Joint Bone Spine; 2007 Dec; 74(6):627-37. PubMed ID: 18037319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with ankylosing spondylitis or psoriatic arthritis: 2007 update.
    Pham T; Fautrel B; Dernis E; Goupille P; Guillemin F; Le Loët X; Ravaud P; Claudepierre P; Miceli-Richard C; de Bandt M; Breban M; Maillefert JF; Masson C; Saraux A; Schaeverbeke T; Wendling D; Mariette X; Combe B;
    Joint Bone Spine; 2007 Dec; 74(6):638-46. PubMed ID: 18065252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations of the French Society for Rheumatology. TNFalpha antagonist therapy in rheumatoid arthritis.
    Fautrel B; Constantin A; Morel J; Vittecoq O; Cantagrel A; Combe B; Dougados M; Le Loët X; Mariette X; Pham T; Puéchal X; Sibilia J; Soubrier M; Ravaud P;
    Joint Bone Spine; 2006 Jul; 73(4):433-41. PubMed ID: 16798046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update of French society for rheumatology recommendations for managing rheumatoid arthritis.
    Daien C; Hua C; Gaujoux-Viala C; Cantagrel A; Dubremetz M; Dougados M; Fautrel B; Mariette X; Nayral N; Richez C; Saraux A; Thibaud G; Wendling D; Gossec L; Combe B
    Joint Bone Spine; 2019 Mar; 86(2):135-150. PubMed ID: 30315988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
    Keating GM; Perry CM
    BioDrugs; 2002; 16(2):111-48. PubMed ID: 11985485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNFalpha antagonist therapy in ankylosing spondylitis and psoriatic arthritis: recommendations of the French Society for Rheumatology.
    Pham T; Guillemin F; Claudepierre P; Luc M; Miceli-Richard C; Fautrel B; de Bandt M; Breban M; Goupille P; Maillefert JF; Masson C; Saraux A; Schaeverbeke T; Wendling D; Mariette X; Combe B; ;
    Joint Bone Spine; 2006 Oct; 73(5):547-53. PubMed ID: 16843030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of discontinuing TNFalpha antagonist therapy in patients with remission of rheumatoid arthritis.
    Brocq O; Millasseau E; Albert C; Grisot C; Flory P; Roux CH; Euller-Ziegler L
    Joint Bone Spine; 2009 Jul; 76(4):350-5. PubMed ID: 19362504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
    Smolen JS; Kay J; Doyle MK; Landewé R; Matteson EL; Wollenhaupt J; Gaylis N; Murphy FT; Neal JS; Zhou Y; Visvanathan S; Hsia EC; Rahman MU;
    Lancet; 2009 Jul; 374(9685):210-21. PubMed ID: 19560810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2018 update of French Society for Rheumatology (SFR) recommendations about the everyday management of patients with spondyloarthritis.
    Wendling D; Lukas C; Prati C; Claudepierre P; Gossec L; Goupille P; Hudry C; Miceli-Richard C; Molto A; Pham T; Saraux A; Dougados M
    Joint Bone Spine; 2018 May; 85(3):275-284. PubMed ID: 29407043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNFα antagonist therapy does not increase the Epstein-Barr virus burden in patients with rheumatoid arthritis or ankylosing spondylitis.
    Couderc M; Payet S; Henquell C; Dubost JJ; Soubrier M
    Joint Bone Spine; 2010 Oct; 77(5):414-7. PubMed ID: 20542718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching between TNFalpha antagonists in rheumatoid arthritis: personal experience and review of the literature.
    Scrivo R; Conti F; Spinelli FR; Truglia S; Magrini L; Di Franco M; Ceccarelli F; Valesini G
    Reumatismo; 2009; 61(2):107-17. PubMed ID: 19633797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF alpha antagonist therapy and safety monitoring.
    Pham T; Bachelez H; Berthelot JM; Blacher J; Bouhnik Y; Claudepierre P; Constantin A; Fautrel B; Gaudin P; Goëb V; Gossec L; Goupille P; Guillaume-Czitrom S; Hachulla E; Huet I; Jullien D; Launay O; Lemann M; Maillefert JF; Marolleau JP; Martinez V; Masson C; Morel J; Mouthon L; Pol S; Puéchal X; Richette P; Saraux A; Schaeverbeke T; Soubrier M; Sudre A; Tran TA; Viguier M; Vittecoq O; Wendling D; Mariette X; Sibilia J
    Joint Bone Spine; 2011 May; 78 Suppl 1():15-185. PubMed ID: 21703545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
    Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A
    Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasculitides induced by TNFalpha antagonists: a study in 39 patients in France.
    Saint Marcoux B; De Bandt M;
    Joint Bone Spine; 2006 Dec; 73(6):710-3. PubMed ID: 17127088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Assessment of the Different American College of Rheumatology/European League Against Rheumatism Remission Definitions for Rheumatoid Arthritis for Their Use as Clinical Trial End Points.
    Mack ME; Hsia E; Aletaha D
    Arthritis Rheumatol; 2017 Mar; 69(3):518-528. PubMed ID: 27696724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proposal for anti-TNFalpha therapy in adult patients with rheumatoid arthritis].
    Curković B; Babić-Naglić D; Morović-Vergles J; Anić B; Grazio S
    Reumatizam; 2008; 55(1):22-5. PubMed ID: 19024266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current treatment of psoriatic arthritis: update based on a systematic literature review to establish French Society for Rheumatology (SFR) recommendations for managing spondyloarthritis.
    Paccou J; Wendling D
    Joint Bone Spine; 2015 Mar; 82(2):80-5. PubMed ID: 24997741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNFalpha antagonists in rheumatoid arthritis patients seen in everyday practice.
    Falgarone G; Duclos M; Boissier MC
    Joint Bone Spine; 2007 Dec; 74(6):523-6. PubMed ID: 18092377
    [No Abstract]   [Full Text] [Related]  

  • 19. Infliximab therapy in established rheumatoid arthritis: an observational study.
    Voulgari PV; Alamanos Y; Nikas SN; Bougias DV; Temekonidis TI; Drosos AA
    Am J Med; 2005 May; 118(5):515-20. PubMed ID: 15866254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice.
    Bombardieri S; Ruiz AA; Fardellone P; Geusens P; McKenna F; Unnebrink K; Oezer U; Kary S; Kupper H; Burmester GR;
    Rheumatology (Oxford); 2007 Jul; 46(7):1191-9. PubMed ID: 17504821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.